CL2019000846A1 - Proteína terapéutica. - Google Patents

Proteína terapéutica.

Info

Publication number
CL2019000846A1
CL2019000846A1 CL2019000846A CL2019000846A CL2019000846A1 CL 2019000846 A1 CL2019000846 A1 CL 2019000846A1 CL 2019000846 A CL2019000846 A CL 2019000846A CL 2019000846 A CL2019000846 A CL 2019000846A CL 2019000846 A1 CL2019000846 A1 CL 2019000846A1
Authority
CL
Chile
Prior art keywords
therapeutic protein
therapy
deflamin
nutraceutical
cancer
Prior art date
Application number
CL2019000846A
Other languages
English (en)
Inventor
Ana Isabel Gusmão Lima
Joana Patrícia Mota Guerreiro
Ricardo Manuel De Seixas Boavida Ferreira
Original Assignee
Inst Superior Agronomia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PT109645A external-priority patent/PT109645A/pt
Priority claimed from GBGB1616715.7A external-priority patent/GB201616715D0/en
Application filed by Inst Superior Agronomia filed Critical Inst Superior Agronomia
Publication of CL2019000846A1 publication Critical patent/CL2019000846A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

UNA COMPOSICIÓN DE POLIPÉPTIDO DE DEFLAMINA PARA USO EN UN MÉTODO DE TRATAMIENTO DEL CUERPO HUMANO O ANIMAL MEDIANTE TERAPIA EN DONDE LA TERAPIA PREFERIBLEMENTE PREVIENE O TRATA LA INFLAMACIÓN O EL CÁNCER, O PROPORCIONA UN NUTRACÉUTICO.
CL2019000846A 2016-09-30 2019-03-29 Proteína terapéutica. CL2019000846A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT109645A PT109645A (pt) 2016-09-30 2016-09-30 Composição de polipéptidos da deflamina, sua utilização num método de tratamento e sua preparação, vetores de ácido nucleico que a expressam e anticorpo para aqueles polipéptidos
GBGB1616715.7A GB201616715D0 (en) 2016-09-30 2016-09-30 Therapeutic protein

Publications (1)

Publication Number Publication Date
CL2019000846A1 true CL2019000846A1 (es) 2019-11-15

Family

ID=60582543

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019000846A CL2019000846A1 (es) 2016-09-30 2019-03-29 Proteína terapéutica.

Country Status (14)

Country Link
US (1) US20200113969A1 (es)
EP (1) EP3518957B1 (es)
JP (1) JP7510255B2 (es)
KR (1) KR20190061015A (es)
CN (1) CN110214017B (es)
AU (1) AU2017334047B2 (es)
BR (1) BR112019006174A2 (es)
CA (1) CA3037800A1 (es)
CL (1) CL2019000846A1 (es)
CO (1) CO2019003865A2 (es)
IL (1) IL265708A (es)
MX (1) MX2019003751A (es)
WO (1) WO2018060528A2 (es)
ZA (1) ZA201902689B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7304053B2 (ja) * 2019-02-15 2023-07-06 国立大学法人金沢大学 肝臓がん発症リスクの判定方法、及び肝臓がん発症リスクの判定キット
CN112753943A (zh) * 2021-01-27 2021-05-07 上海理工大学 一种具有炎症性肠病调节功能的能量棒及其制作方法
CN112772843A (zh) * 2021-01-27 2021-05-11 上海理工大学 一种适用于ibd炎症性肠病患者食用的代餐粉及其制备方法
CN114106083A (zh) * 2021-12-09 2022-03-01 南开大学 一种小米蛋白和小米蛋白水解物的制备方法及小米蛋白水解物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041308A1 (it) * 2004-06-29 2004-09-29 Fraunhofer Ges Zur Foerderung... Processo per la purificazione da seme di lupiom di frazioni proteiche attive sul metabolismo lipidico
SI2221383T1 (sl) 2005-07-21 2015-10-30 Instituto Superior De Agronomia Nukleotidna sekvenca, ki kodira proti-glivični polipeptid
WO2008144939A1 (en) * 2007-06-01 2008-12-04 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food A process of aqueous protein extraction from brassicaceae oilseeds
DK2310037T3 (da) * 2008-05-30 2014-10-27 Policlinico San Donato S P A Istituto Di Ricovero E Cura A Carattere Scient Conglutin-gamma as-medikament og -kosttilskudpatentkrav
MX344183B (es) 2010-10-12 2016-12-08 Consumo Em Verde - Biotecnologia Das Plantas S A * Proteina antimicrobiana.

Also Published As

Publication number Publication date
ZA201902689B (en) 2019-11-27
EP3518957B1 (en) 2024-05-15
WO2018060528A2 (en) 2018-04-05
KR20190061015A (ko) 2019-06-04
MX2019003751A (es) 2019-12-16
WO2018060528A3 (en) 2018-07-05
CA3037800A1 (en) 2018-04-05
CN110214017A (zh) 2019-09-06
AU2017334047B2 (en) 2025-01-23
BR112019006174A2 (pt) 2019-06-18
CN110214017B (zh) 2024-07-23
US20200113969A1 (en) 2020-04-16
IL265708A (en) 2019-05-30
CO2019003865A2 (es) 2019-04-30
JP7510255B2 (ja) 2024-07-03
AU2017334047A1 (en) 2019-05-16
EP3518957A2 (en) 2019-08-07
JP2020503060A (ja) 2020-01-30
EP3518957C0 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
MX2020008977A (es) Formulaciones de anticuerpos de her2 subcutaneas.
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
MX2019011858A (es) Metodos para tratar el cancer con anticuerpos dirigidos a ps con agentes inmunooncologicos.
BR112017018954A2 (pt) uso de forma mutante de proteína ras e método para tratar câncer
CO2018014010A2 (es) Anticuerpos a la alfa-sinucleína y usos de los mismos
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
MX2017005258A (es) Terapia combinada para tratamiento de enfermedad.
MX2017015938A (es) Inhibidores de ezh2 para el tratar linfomas.
SV2017005373A (es) Inhibidores de la proteína quinasa c y métodos de su uso
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
MX387283B (es) Tratamiento del cancer con tg02.
BR112017018964A2 (pt) uso de plinabulin e métodos para tratar tumor cerebral
CY1123501T1 (el) Χρηση ρεσλιζουμαμπης για τη θεραπευτικη αντιμετωπιση μετριου εως σοβαρου ηωσινοφιλικου ασθματος
BR112017023517A2 (pt) anticorpo anti-cd20 para tratamento do câncer, composição farmacêutica, método de tratamento de um paciente que sofre de câncer e uso de um anticorpo anti-cd20
CY1123366T1 (el) Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου
CO2020001107A2 (es) Moduladores terapéuticos del modo inverso de la atp sintasa
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
CO2019003865A2 (es) Proteína terapéutica
MX2022002056A (es) Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina.
CY1122882T1 (el) Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου
MX2020001727A (es) Terapia de combinacion.
BR112017025533A2 (pt) método para tratar câncer em um paciente humano
BR112018002530A2 (pt) combinações e usos e tratamentos destas
MX2017016346A (es) Metodos de tratamiento con taselisib.
EA201591902A1 (ru) Способы и композиции, использующие 4-амино-2-(2,6-диоксо-пиперидин-3-ил)изоиндолин-1,3-дион для лечения и контроля злокачественных опухолей центральной нервной системы